
ACS Medicinal Chemistry Letters p. 1335 - 1341 (2020)
Update date:2022-08-02
Topics:
Hiramatsu, Atsushi
Hirooka, Yasuo
Hisaichi, Katsuya
Imagawa, Akira
Iwaki, Yuzo
Katoh, Makoto
Kobayashi, Juta
Komichi, Yuka
Maeda, Tatsuo
Matsumura, Naoya
Moriguchi, Hideki
Nakatani, Shingo
Nishiyama, Taihei
Ohhata, Akira
Okabe, Yasuyuki
Okada, Masahiro
Ota, Hiroto
Saga, Hiroshi
Sugiyama, Tetsuya
Watanabe, Toshihide
Yamamoto, Shingo
Lysophosphatidic acid (LPA) is a bioactive lipid mediator that elicits a number of biological functions, including smooth muscle contraction, cell motility, proliferation, and morphological change. LPA is endogenously produced by autotaxin (ATX) from extracellular lysophosphatidylcholine (LPC) in plasma. Herein, we report our medicinal chemistry effort to identify a novel and highly potent ATX inhibitor, ONO-8430506 (20), with good oral availability. To enhance the enzymatic ATX inhibitory activity, we designed several compounds by structurally comparing our hit compound with the endogenous ligand LPC. Further optimization to improve the pharmacokinetic profile and enhance the ATX inhibitory activity in human plasma resulted in the identification of ONO-8430506 (20), which enhanced the antitumor effect of paclitaxel in a breast cancer model.
View MoreRizhao Lanxing Chemical Indusrial Co.,Ltd
Contact:86-633-2616708
Address:NO.15 West road Shenglan, Lanshan district, Rizhao City
YanCheng LongShen Chemical Co.,Ltd.
Contact:+86-515-86668866
Address:No.13,Weiyi Road,Funing Aoyang Industrial Park
Contact:+86-025-52406782
Address:8 Taizishan Rd., Yanjiang Industrial Development Area, Nanjing, Jiangsu, China.
Shandong Bolode Bio-Technology Co., LTD
Contact:+86-0531-58966870
Address:136 Jingyi Road,Huaiyin District,Jinan,Shandong,China
Taizhou Elitechemie MediPharma Technology Co.,Ltd.
Contact:+86-523-86810021
Address:Building G14,NO.1 Avenue,China Medical City, Taizhou, Jiangsu,China
Doi:10.1021/ja00018a040
(1991)Doi:10.1016/j.bmcl.2011.10.099
(2012)Doi:10.1016/j.tetlet.2005.03.193
(2005)Doi:10.1016/j.inoche.2011.10.004
(2012)Doi:10.1055/s-0031-1289570
(2011)Doi:10.1021/acs.orglett.1c01177
(2021)